Kurs
+4,00%
Kalender
Tid* | ||
2025-02-12 | 09:00 | Bokslutskommuniké 2024 |
2024-11-13 | - | Extra Bolagsstämma 2024 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-07-01 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2024-06-28 | - | Årsstämma |
2024-06-14 | - | Bokslutskommuniké 2023 |
2023-08-24 | - | Kvartalsrapport 2023-Q2 |
2023-06-12 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2023-06-09 | - | Årsstämma |
2023-04-28 | - | Bokslutskommuniké 2022 |
2022-08-24 | - | Kvartalsrapport 2022-Q2 |
2022-06-10 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2022-06-09 | - | Årsstämma |
2022-04-29 | - | Bokslutskommuniké 2021 |
2021-08-25 | - | Kvartalsrapport 2021-Q2 |
2021-06-10 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2021-06-09 | - | Årsstämma |
2021-04-30 | - | Bokslutskommuniké 2020 |
2020-09-11 | - | Extra Bolagsstämma 2020 |
2020-08-26 | - | Kvartalsrapport 2020-Q2 |
2020-06-11 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2020-06-10 | - | Årsstämma |
2020-04-15 | - | Bokslutskommuniké 2019 |
2019-08-28 | - | Kvartalsrapport 2019-Q2 |
2019-06-06 | - | X-dag ordinarie utdelning ABTEC 0.00 NOK |
2019-06-05 | - | Årsstämma |
2019-04-24 | - | Bokslutskommuniké 2018 |
2019-01-07 | - | Extra Bolagsstämma 2019 |
2018-08-22 | - | Kvartalsrapport 2018-Q2 |
2018-05-30 | - | Årsstämma |
2018-02-21 | - | Bokslutskommuniké 2017 |
2017-08-16 | - | Kvartalsrapport 2017-Q2 |
2017-06-08 | - | X-dag ordinarie utdelning ABTEC 1.00 NOK |
2017-06-07 | - | Årsstämma |
2017-02-15 | - | Bokslutskommuniké 2016 |
2016-11-18 | - | X-dag bonusutdelning ABTEC 1 |
2016-11-17 | - | Extra Bolagsstämma 2016 |
2016-11-17 | - | 15-10 2016-Q3 |
2016-08-17 | - | Kvartalsrapport 2016-Q2 |
2016-06-09 | - | X-dag ordinarie utdelning ABTEC 1.50 NOK |
2016-06-08 | - | Årsstämma |
2016-02-10 | - | Bokslutskommuniké 2015 |
2015-11-18 | - | Kvartalsrapport 2015-Q3 |
2015-08-19 | - | Kvartalsrapport 2015-Q2 |
2015-06-04 | - | X-dag ordinarie utdelning ABTEC 1.00 NOK |
2015-06-03 | - | Årsstämma |
2015-05-13 | - | Kvartalsrapport 2015-Q1 |
2015-02-11 | - | Bokslutskommuniké 2014 |
2014-11-26 | - | Kvartalsrapport 2014-Q3 |
2014-08-20 | - | Kvartalsrapport 2014-Q2 |
2014-06-11 | - | Årsstämma |
2014-05-21 | - | Kvartalsrapport 2014-Q1 |
2014-02-12 | - | Bokslutskommuniké 2013 |
2013-11-27 | - | Kvartalsrapport 2013-Q3 |
2013-08-21 | - | Kvartalsrapport 2013-Q2 |
2013-06-13 | - | Kapitalmarknadsdag 2013 |
2013-06-12 | - | X-dag ordinarie utdelning |
2013-06-11 | - | Årsstämma |
2013-05-22 | - | Kvartalsrapport 2013-Q1 |
2013-02-13 | - | Bokslutskommuniké 2012 |
2012-11-27 | - | Kvartalsrapport 2012-Q3 |
2012-08-28 | - | Kvartalsrapport 2012-Q2 |
2012-06-14 | - | Årsstämma |
2012-05-23 | - | Kvartalsrapport 2012-Q1 |
2012-02-17 | - | Bokslutskommuniké 2011 |
2011-11-30 | - | Kvartalsrapport 2011-Q3 |
2011-08-29 | - | Kvartalsrapport 2011-Q2 |
2011-06-17 | - | X-dag ordinarie utdelning |
2011-06-16 | - | Årsstämma |
2011-05-30 | - | Kvartalsrapport 2011-Q1 |
2011-02-18 | - | Bokslutskommuniké 2010 |
Beskrivning
Land | Norge |
---|---|
Lista | OAX Equities |
Sektor | Hälsovård |
Industri | Bioteknik |
25.4.2024 21:18:52 CEST | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state
Aqua Bio Technology ASA ("ABT", and together with its subsidiaries, the "Group") has, as of the first quarter of 2024, achieved NOK 35 million in gross revenues on a consolidated basis with a positive EBITDA. The Group subsidiary, Cover Brands AS, was consolidated into the Group's financial accounts from 1 January 2024. On 12 April 2024, ABT completed the acquisition of Ovalen AS, which will be consolidated into the Group's financial accounts with effect from 1 May 2024. The Group's revenues for the first quarter of 2024 has not been audited.
Considering that Q1 is typically the weakest quarter in this segment, with 60% of annual turnover normally occurring in Q3 and Q4, ABT is on track with its previous guidance for a turnover of NOK 140-150 million in 2024. With the integration of Ovalen AS (www.pusteromhudpleie.no) starting from Q2, and assuming satisfactory due diligence and the completion of the acquisition of 3D Innovation Nordic AS and its affiliated companies in Q2, ABT anticipates that the turnover for 2024 will reach NOK 200-210 million and that the pro forma turnover for 2024 for the Group will exceed NOK 250 million.
Following ABT's acquisition activity, the preparation of the Group's annual financial statements for 2023 has taken longer than anticipated. Consequently, ABT updates its financial calendar as follows:
FINANCIAL YEAR 2023
14.06.2024 – Annual Report
FINANCIAL YEAR 2024
23.08.2024 – Half-yearly Report
28.06.2024 – Annual General Meeting
06.11.2024 – Quarterly Report – Q3
12.02.2025 – Quarterly Report – Q4
This information is published in accordance with the requirements of the Continuing Obligations in Euronext Oslo Børs Rule Book II.
Disclosure regulation
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
- Håvard Lindstrøm, 004794132288, hl@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.